홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트：[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 10941생성일: 2026년 10월 30일

염산 m-페닐렌 디아민

M-페닐렌디아민디수화염화물 · 염산m-페닐렌디아민 · 1,3-벤젠디아민염산염 · M-페닐렌디아민디수화염화물(M-PHENYLENEDIAMINEDIHYDROCHLORIDE) · 1,3-벤젠다이아민 다이하이드로클로라이드 · 1,3-벤젠다이아민, 염산염 (1:2) · 1,3-벤젠다이아민, 이염산염 · 1,3-벤젠디아민 염산염

https://huagongshe.com/ko/chemical/10941

염산 m-페닐렌 디아민 분자 구조식

식별자 및 물리적 특성

CAS No.541-69-5
분자식C6H8N2.2ClH
평균 분자량181.06 g/mol
단동위원소 질량180.0221037 g/mol
SMILESCl.Cl.Nc1cccc(N)c1
InChIKeySVTOYMIYCMHPIV-UHFFFAOYSA-N
PubChem CID10941
ChEMBLCHEMBL3182234
EC No.208-790-0
DTXSIDDTXSID4021139
현지명염산 m-페닐렌 디아민

화학 및 물리적 성질

극성 표면적52
수소 결합 공여자 수4
수소 결합 수용자 수2
회전 가능 결합 수0
무거운 원자 수10
형식 전하0
복잡도64.9
물질 분류Nitrogen Compounds -> Amines, Aromatic
Color/FormWhite or slightly red crystalline powder
용해도Freely soluble in watersoluble in alcohol
DecompositionWhen heated to decomposition it emits very toxic fumes of HCl and nitrogen oxides.
Physical DescriptionOff-white powder[MSDSonline]
녹는점260°C (dec.)
물리적 상태결정성 분말
색상라이트베이지~그레이베이지
용해도자유롭게 용해되는
Merck14,7283
BRN3911748
안정성안정적인. 강한 산화제와 호환되지 않습니다.
InChI1S/C6H8N2.2ClH/c7-5-2-1-3-6(8)4-5/h1-4H,7-8H22*1H
InChIKeySVTOYMIYCMHPIV-UHFFFAOYSA-N
SMILESCl.Cl.Nc1cccc(N)c1
EPAm-Phenylenediamine dihydrochloride (541-69-5)

화학적 성질

white to slightly red crystalline powder

안전 및 규제

GHS 분류DangerH301: Toxic if swallowed [Danger Acute toxicity, oral]P203, P261, P262, P264, P264+P265, P270, P271, P272, P273, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P318, P321, P330, P333+P317, P337+P317, P361+P364, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
규제 정보Chemical: 1,3-Benzenediamine, dihydrochloride
기타 안전 정보IMAP assessments - 1,3-Benzenediamine, dihydrochloride: Human health tier II assessment
유해성 요약Has the potential to form methemoglobinEmergency treatment: ParaphenylenediamineIn sensitized individuals, paraphenylenediamine may cause allergic contact dermatitis following application as a hair dye and asthma following inhalationFollowing ingestion, can cause angioneurotic edema, methemoglobinemia, acute tubular necrosis, and hepatotoxicityAn adult died after ingestion of 3 grams of p-phenylenediamineAnother adult who ingested 1800 mg developed angioneurotic edema and acute renal failure[HSDB] An eye irritantMay cause skin sensitization[eChemPortal: ESIS] An irritantCan be absorbed through skin[MSDSonline] See p-Phenylenediamine.
Special ReportsUSEPAPHENYLENEDIAMINESRESPONSE TO INTERAGENCY TESTING COMMITTEEFED REGIST 47(5) 973 (1982). EVIDENCE IS GIVEN SUPPORTING TESTING OF THE CLASS OF COMPOUNDS PHENYLENEDIAMINES FOR THEIR TOXIC EFFECTS ON HUMAN HEALTH AND THE ENVIRONMENT. THE RESULTS OF TOXICITY TESTING OF 22 COMPOUNDS ARE TABULATED AS ARE THE EFFECTS FOR WHICH TESTING IS BEING CONSIDERED FOR 13 COMPOUNDS, AND THE USES OR POTENTIAL USES OF 47 PHENYLENEDIAMINES.
TSCA 요건Pursuant to section 8(d) of TSCA, EPA promulgated a model Health and Safety Data Reporting Rule. The section 8(d) model rule requires manufacturers, importers, and processors of listed chemical substances and mixtures to submit to EPA copies and lists of unpublished health and safety studies. 1,3-Benzenediamine dihydrochloride is included on this list.
Hazard Classes and Categories

용도

용도

m-Phenylenediamine dihydrochloride is used in the synthesis of bis(thiazolidone) and bis(thiohydantoin) derivatives. It can be used to increase the pore size in the fabrication of poly(aniline-co-1,3-phenylenediamine) cryogels.

Acute Tox. 3 (100%)Germ cell mutagenicity - category 2Acute toxicity (Oral) - Category 3Muta. 2
처리 방법SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.
유해 작용Occupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.
TSCA Test Submissionsm-Phenylenediamine dihydrochloride (CAS # 541-69-5) was evaluated for carcinogenicity in mice (25/sex/treatment group, strain unspecified) exposed to dietary concentrations of 0, 2000 and 4000 ppm for 18 months. Beginning late in treatment (at least 8 months), mice were periodically sacrificed for necropsy and evaluation of gross pathology (protocol was not provided). Those mice displaying gross pathology and any late term (8 months or more after initiation of treatment) non-autolyzed lethalities were used for histological determinations of carcinogenicity. Mice remaining after serial sacrifice were kept until death (as long as 19 months) for observation of clinical toxicity and terminal histopathological evaluation. Study mortality was 100% in high- and low-dose groups of both sexes at 15 months and 19 months respectively. Survival was also noted to be markedly diminished and mean bodyweights were reduced at 12 months in both high-dose male and female mice relative to controls. With 16/25, 10/25 and 15/25 of control mice, and male high and low dose mice effectively available for carcinogenicity analysis respectively, no significant increased incidence of tumors was identified relative to controls: Investigators considered number of mice with tumors, number of tumors, mice with multiple tumors, and type tumor incidence relative to those values in controls. Only in female low-dose mice (13 final effective number) was marked increased incidence of tumors relative to controls (13 final effective number) observed: Female low-dose mice were found with 31% lung tumors relative to 23% incidence in control mice and 8% hepatomas relative to 0 incidence in controls. Amyloid bodies were noted from 12 months in both low- and high-dose male and female mice.m-Phenylenediamine dihydrochloride (CAS # 541-69-5) was evaluated for carcinogenicity in male rats (25/treatment group, strain unspecified) exposed to dietary concentrations of 0, 1000 and 2000 ppm for 18 months. Beginning late in treatment, animals were periodically sacrificed for necropsy and evaluation of gross pathology (protocol was not provided)A first tumor was noted at 15 weeks. Those rats displaying gross pathology and any late term non-autolyzed lethalities were used for histological determinations of carcinogenicity. Rats remaining after serial sacrifice were kept until death (as long as 26 months) for observation of clinical toxicity and terminal histopathological evaluation. Study mortality was 100% in high-dose rats at 15 months. Low-dose rats showed recovery of some lost bodyweight at Week 20 after discontinuation of treatment. With 111/150, 15/25 and 17/25 of control rats, and high- and low-dose rats effectively available for carcinogenicity analysis respectively, both low- and high-dose rats were found with a higher incidence of GI and liver tumors relative to controls. Investigators considered number of mice with tumors, number of tumors, mice with multiple tumors, and type tumor incidence relative to those values in controls. Treated rats showed generally lower incidence (40% and 41% of high and low dose rats respectively) carcinogenicity than did controls (59%).
Human Toxicity Excerpts/SRP/: POTENTIAL METHEMOGLOBIN FORMER.Poison by intraperitoneal route. Questionable carcinogen with experimental tumorigenic data. Mutation data reported.
Non-Human Toxicity Excerpts4 GROUPS, EACH OF 5 WISTAR-KING RATS WERE TREATED...WITH...META-PHENYLENEDIAMINE HYDROCHLORIDE @ DOSE OF 12 OR 24 MG/KG BODY WT. ...INJECTED SUBCUTANEOUSLY INTO THE BACK ON ALTERNATE DAYS, FOR 5 MO IN THE HIGHER DOSE GROUPS AND FOR 11 MO IN THE LOWER DOSE GROUPS. ... FIBROSARCOMAS WERE PRODUCED IN ONE RAT IN THE GROUP TREATED WITH...24 MG/KG BODY WT... NO TUMORS WERE FOUND IN ANY OF THE OTHER GROUPS NOR IN THE CONTROL GROUPS.
Evidence for CarcinogenicityNo data are available in humans. Inadequate evidence of carcinogenicity in animals. OVERALL EVALUATION: Group 3: The agent is not classifiable as to its carcinogenicity to humans. /M-Phenylenediamine/
Antidote and Emergency TreatmentFor immediate first aid: Ensure that adequate decontamination has been carried out. If victim is not breathing, start artificial respiration, preferably with a demand-valve resuscitator, bag-valve-mask device, or pocket mask as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep victim quiet and maintain normal body temperature. Obtain medical attention. /Organic bases, amines, and related compounds/For basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... Monitor for shock and treat if necessary ... Anticipate seizures and treat if necessary ... For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool. Administer activated charcoal ... Cover skin burns with sterile dressings after decontamination ... . /Organic bases, amines, and related compounds/
Non-Human Toxicity ValuesLD50 Mouse sc 120 mg/kg body weight
수질 위해 등급(WGK)3
TSCA 등재 상태TSCA listed
RTECS 번호SS9800000
운송 번호(UN)UN 2811 6.1/PG 3
관세 코드29215900
위험 문구(R)23/24/25-36-40-43-50/53-68
위험 표시T,N
안전 문구(S)28-36/37-45-60-61-28A
포장분류III
위험 등급6.1Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralAquatic Acute 1Aquatic Chronic 1Eye Irrit. 2Muta. 2Skin Sens. 1
기존화학 물질KE-05-1004
F 고인화성물질8-9-23
저장 분류6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
유해 물질 데이터541-69-5(Hazardous Substances Data)
함량 및 규제정보물질구분: 유독물질혼합물(제품)함량정보: 페닐렌디아민과 그 염류 및 이를 25% 이상 함유한 혼합물
유해화학물질 필터링97-1-334